[Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)].
D000293:Adolescent; D000328:Adult; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D006975:Hypertension, Portal / Q000188:drug therapy; D007546:Isoquinolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000577:Amides; D000959:Antihypertensive Agents; D007546:Isoquinolines
Experiencia clińica con un nuevo bloqueador postganglionar (Debrisoquine R0-5-3307.